NGS molecular profiling across 14+ cancer-specific panels to guide targeted therapy.
Tumor Testing provides next-generation sequencing (NGS) molecular profiling across 14+ cancer-specific panels. By matching a tumor's molecular profile to targeted therapies, it helps oncologists optimize treatment for each patient.